Tortugas Neuroscience

Framingham, United States · Founded 2021 · $106.0M raised

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$106.0M
Last Round
$106.0M Series AApr 2026
Rounds
1

About

Tortugas Neuroscience is a neurology-focused biotech company dedicated to developing novel medicines with derisked mechanisms of action for large, well-defined central nervous system indications. Launched in April 2026 with $106 million in Seed and Series A financing, the company is led by biotech veterans Jeff Jonas, M.D. (CEO) and Al Robichaud, Ph.D. (President, Head of R&D), both formerly of Sage Therapeutics. Its clinical-stage pipeline includes in-licensed programs from Eisai and Jiangsu Hansoh Pharmaceutical targeting schizophrenia, tinnitus, focal epilepsy, and reversible encephalopathies, with a strategic focus on once-daily oral formulations and clear regulatory pathways to approval.

Summary

Tortugas Neuroscience is a Biotech company based in Framingham, United States, founded in 2021. It has raised $106.0M in total across 1 round, most recently a $106.0M Series A round in Apr 2026. Investors include The Column Group, Cure Ventures and AN Venture Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2026
$106.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tortugas Neuroscience on Indexed.vc
<a href="https://indexed.vc/companies/tortugas-neuroscience"><img src="https://indexed.vc/api/badge/company/tortugas-neuroscience" alt="Tortugas Neuroscience on Indexed.vc" width="260" height="76" /></a>